Identification of virulence factors genes in Escherichia coli isolates from women with urinary tract infection in Mexico.
Daniela A López-BandaErika M Carrillo-CasasMargarita Leyva-LeyvaGabriel Orozco-HoyuelaÁngel H Manjarrez-HernándezSara Arroyo-EscalanteDavid Moncada-BarrónSilvia Villanueva-RecillasJuan Xicohtencatl-CortesRigoberto Hernández-CastroPublished in: BioMed research international (2014)
E coli isolates (108) from Mexican women, clinically diagnosed with urinary tract infection, were screened to identify virulence genes, phylogenetic groups, and antibiotic resistance. Isolates were identified by MicroScan4 system; additionally, the minimum inhibitory concentration (MIC) was assessed. The phylogenetic groups and 16 virulence genes encoding adhesins, toxins, siderophores, lipopolysaccharide (LPS), and invasins were identified by PCR. Phylogenetic groups distribution was as follows: B1 9.3%, A 30.6%, B2 55.6%, and D 4.6%. Virulence genes prevalence was ecp 98.1%, fimH 86.1%, traT 77.8%, sfa/focDE 74.1%, papC 62%, iutA 48.1%, fyuA 44.4%, focG 2.8%, sfaS 1.9%, hlyA 7.4%, cnf-1 6.5%, cdt-B 0.9%, cvaC 2.8%, ibeA 2.8%, and rfc 0.9%. Regarding antimicrobial resistance it was above 50% to ampicillin/sulbactam, ampicillin, piperacillin, trimethoprim/sulfamethoxazole, ciprofloxacin, and levofloxacin. Uropathogenic E. coli clustered mainly in the pathogenic phylogenetic group B2. The isolates showed a high presence of siderophores and adhesion genes and a low presence of genes encoding toxins. The high frequency of papC gene suggests that these isolates have the ability to colonize the kidneys. High resistance to drugs considered as first choice treatment such as trimethoprim/sulfamethoxazole and fluoroquinolones was consistently observed.
Keyphrases
- escherichia coli
- antimicrobial resistance
- genome wide
- urinary tract infection
- genome wide identification
- bioinformatics analysis
- biofilm formation
- pseudomonas aeruginosa
- high frequency
- staphylococcus aureus
- genome wide analysis
- dna methylation
- transcranial magnetic stimulation
- inflammatory response
- cystic fibrosis
- klebsiella pneumoniae
- type diabetes
- metabolic syndrome
- pregnant women
- toll like receptor
- copy number
- skeletal muscle
- immune response
- candida albicans
- risk factors
- replacement therapy
- acinetobacter baumannii
- smoking cessation